NEJM — Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Information for this posting was provided by Karen D., in South Florida: Published at www.nejm.org January 20, 2010 (10.1056/NEJMoa0907839) Background…
Novartis oral MS therapy FTY720 shows reduced risk of confirmed disability progression
January 21, 2010 Results of the TRANSFORMS(1) and FREEDOMS(2) studies, the two pivotal Phase III clinical trials with oral FTY720…
Stuart Schlossman
Oral Therapy for Multiple Sclerosis — Sea Change or Incremental Step?
January 20, 2010 – New England Journal of Medicine written by: William M. Carroll, M.B., B.S., M.D., F.R.A.C.P. The long-awaited…
Stuart Schlossman
